Increase in Chronic Digestive Disorders Seen During Pandemic

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 9, 2025.

via HealthDay

WEDNESDAY, July 9, 2025 -- There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a study recently published online in Neurogastroenterology & Motility.

Christopher V. Almario, M.D., from Cedars-Sinai in Los Angeles, and colleagues assessed trends in the prevalence of Rome IV gastroduodenal and bowel DGBI over time based on survey responses from a nationally representative sample of more than 160,000 U.S. adults.

The researchers found that during the COVID-19 pandemic, the prevalence of irritable bowel syndrome (IBS) increased (6.1 [May 2020] to 11.0 percent [May 2022]; +0.188 percent/month), as did chronic idiopathic constipation (6.0 [May 2020] to 6.4 percent [May 2022]; +0.056 percent/month). The largest prevalence increase was seen in mixed IBS (+0.085 percent/month), IBS with constipation (+0.041 percent/month), and IBS with diarrhea (+0.037 percent/month). For the other examined gastroduodenal and bowel DGBI, there were no changes in prevalence.

"These findings underscore the significant toll the pandemic has taken on digestive health," Almario said in a statement. "These disorders involve chronic gastrointestinal symptoms that are often triggered or worsened by psychological stress."

Several authors disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-10 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords